Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    73,840

Stocks News & Analysis

stocks

Continuing problems at the ASX

Interim report by financial regulator is a hit to sentiment.
stocks

Top investing lessons from 2025

13 lessons from Morningstar’s James Gruber.
stocks

Chart of the Week: Aussie dividend yields are less attractive than alternatives

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,875.7032.600.37%
CAC 408,121.3535.300.44%
DAX 4024,096.39135.800.57%
Dow JONES (US)48,211.67325.700.68%
FTSE 1009,782.157.830.08%
HKSE25,498.1329.350.12%
NASDAQ23,026.72333.401.47%
Nikkei 22549,001.50510.78-1.03%
NZX 50 Index13,256.7739.14-0.29%
S&P 5006,789.0167.581.01%
S&P/ASX 2008,588.2031.700.37%
SSE Composite Index3,876.376.090.16%

Market Movers